Chlamydia

Introduction

  1. Chlamydia is one of the most common sexually transmitted infections (STIs) worldwide.
  2. It is caused by the bacterium Chlamydia trachomatis infection, mainly due to the organism Chlamydia trachomatis.
  3. The infection often remains asymptomatic, especially in women, which makes early detection difficult.
  4. Untreated infection may lead to serious complications such as infertility and pelvic inflammatory disease.
  5. Chlamydia mainly affects the genital tract but can also infect the eyes, rectum, throat, and respiratory tract.
  6. It spreads through sexual contact, including vaginal, anal, and oral intercourse.
  7. Newborn babies can acquire infection during childbirth from infected mothers.
  8. Chlamydia is an important public health problem because of its high prevalence among young adults

General Character

  • Genus: Chlamydia
  • Key Species:
    • Chlamydia trachomatis (causes chlamydial infections, including sexually transmitted infections and trachoma)
    • Chlamydia pneumoniae (causes respiratory infections)
    • Chlamydia psittaci (causes psittacosis or parrot fever)
  • Family: Chlamydiaceae
  • Gram Staining: Chlamydia species are Gram-negative but are not visible using standard Gram staining due to their unique structure.
  • Shape and Arrangement:
    • Shape: Spherical or ovoid.
    • Arrangement: Typically found as individual organisms.
  • Oxygen Requirements: Chlamydia species are obligate intracellular pathogens, requiring host cells for growth and replication.

Morphology

  • Chlamydia trachomatis is a very small bacterium and cannot be seen clearly with ordinary light microscopy without special staining.
  • It is spherical to oval (coccoid) in shape.
  • Size is approximately 0.2–0.3 µm for elementary bodies and 0.5–1 µm for reticulate bodies.
  • It is Gram-negative–like, but stains poorly by Gram stain because it lacks a typical peptidoglycan layer.
  • The organism is non-motile 🚫
  • It is non-spore forming
  • It has no capsule
  • It is an obligate intracellular organism, so it survives and multiplies only inside host cells.

Morphological Forms

1. Elementary Body (EB)

  • Small, dense, extracellular infectious form
  • Diameter about 0.2–0.3 µm
  • Metabolically inactive
  • Resistant to environmental stress
  • Responsible for transmission of infection

2. Reticulate Body (RB)

  • Larger intracellular non-infectious form
  • Diameter about 0.5–1 µm
  • Metabolically active
  • Multiplies by binary fission inside host cell

Inclusion Bodies

  • During multiplication, chlamydia forms intracytoplasmic inclusion bodies inside epithelial cells.
  • These inclusions can be demonstrated by:
    • Giemsa stain
    • Iodine stain

Cultural Characteristics

  • Chlamydia trachomatis does not grow on ordinary artificial media because it is an obligate intracellular bacterium.
  • It requires living cells for cultivation.
  • It is commonly grown in cell culture systems such as:
    • McCoy cells
    • HeLa cells
    • Buffalo green monkey kidney cells
  • Clinical specimens are inoculated into susceptible cell lines and incubated at 35–37°C.
  • Growth occurs inside host cells by formation of intracytoplasmic inclusion bodies.
  • Inclusion bodies can be demonstrated by:
    • Giemsa stain
    • Iodine stain
    • Fluorescent antibody staining
  • Cycloheximide is often added to enhance growth by inhibiting host cell metabolism.
  • The organism can also be grown in the yolk sac of embryonated eggs.
  • Culture usually takes 48–72 hours for visible inclusion formation.
  • Because culture is difficult and time-consuming, molecular methods are now more commonly used.

Biochemical Reactions

  • Catalase Test: Chlamydia species are catalase-positive.
  • Oxidase Test: Chlamydia species are oxidase-negative.
  • Carbohydrate Utilization: Chlamydia does not ferment carbohydrates but relies on host cell metabolism.

Pathogenicity

  • Virulence Factors:
    • Adhesins: Allow attachment to host epithelial cells.
    • Immune Evasion: Chlamydia can modulate the host immune response, allowing persistence within cells.
  • Clinical Infections:
    • Chlamydia trachomatis:
      • Causes chlamydial infections, the most common bacterial STI. Symptoms can include urethritis, cervicitis, and pelvic inflammatory disease (PID). Asymptomatic cases are common, especially in women.
      • It can lead to serious complications such as infertility and ectopic pregnancy.
      • Trachoma: A chronic eye infection that can lead to blindness if untreated.
    • Chlamydia pneumoniae:
      • Causes respiratory infections, including pneumonia and bronchitis, particularly in young adults and older populations.
    • Chlamydia psittaci:
      • Causes psittacosis, primarily associated with exposure to infected birds, leading to flu-like symptoms, pneumonia, and systemic illness.

Laboratory Diagnosis

  • Specimen Collection: Clinical specimens may include urine, cervical swabs, conjunctival swabs, or respiratory samples.
  • Microscopic Examination:
    • Direct visualization is challenging; specialized staining methods can be used to identify inclusions in infected cells.
  • Culture Techniques:
    • Inoculation in tissue culture; growth may take several days to weeks.
  • Serological Testing:
    • Tests can detect antibodies against Chlamydia species, but these may not be specific.
  • Molecular Methods: PCR is increasingly used for rapid and specific detection of Chlamydia DNA in clinical specimens.

Antibiotic Resistance

  • Emergence of Resistance: There is limited data on antibiotic resistance in Chlamydia, but some resistance has been observed, particularly to azithromycin.
  • Treatment Options:
    • Chlamydia trachomatis: Treatment typically includes azithromycin or doxycycline. Partner treatment is essential to prevent reinfection.
    • Chlamydia pneumoniae: Often treated with tetracyclines or macrolides.

Prevention

  • Safe Practices: Practicing safe sex, including the use of condoms, can significantly reduce the risk of chlamydial infections.
  • Public Health Education: Awareness about transmission routes and symptoms is crucial for early detection and treatment.
  • Screening: Regular screening for sexually transmitted infections is recommended, particularly for high-risk populations.

 

Scroll to Top
Enable Notifications OK No thanks